EQT Logo
Current Portfolio

Imcyse

Imcyse develops active specific immunotherapies for the treatment and prevention of severe chronic diseases.

Key Facts
Sector

Life Sciences

Country

Belgium

Fund

LSP 6

Entry

2019

Website

Imcyse

A 3D molecular structure with interconnected hexagonal patterns.

Do You Want to Know More?

We are eager to explore how we can achieve great things together.